8-K ·Filed Jun 10, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Routine board refresh with no operational or financial implications. No actionable trading signal; monitor upcoming quarterly filings for any strategic shifts.
Latest settled — T+20d ⚠ clustered
VIR ▲ +21.36% at T+20d
NEUTRAL call ✓ call won +21.36% · α vs SPY +19.47% · entry $8.52 → $10.34
Latest observation: T+57 +59.22% FF3 residual α
T+1d
+1.06%
call +1.06% · α +0.52%
$8.61
settled 4mo ago
T+5d
+9.15%
call +9.15% · α +8.72%
$9.30
settled 4mo ago
T+20d
+21.36%
call +21.36% · α +19.47%
$10.34
settled 3mo ago
T+60d
—
call — · α —
—
due 28d ago
Price Chart
Loading chart...
Executive Summary
Vir Biotechnology appointed Timothy Coughlin, CPA, as a new Class III director and Audit Committee Chair, expanding the board from 7 to 8 members. This is a routine governance change with no financial impact or strategic implications disclosed.
Key Facts
- Board expanded from 7 to 8 members; Timothy Coughlin appointed to fill new vacancy
- Coughlin will serve as Class III director until 2028 annual meeting and as Audit Committee Chair
- No arrangement or understanding with any person triggered the appointment; no related party transactions
- Coughlin receives standard non-employee director compensation per existing policy, including stock option and RSU grants under the 2019 Equity Incentive Plan
Financial Impact
Standard director compensation; no material financial impact disclosed
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-042237 |
| Document: 0001628280-26-042237-index-headers.html | 0001628280-26-042237 |
| Document: 0001628280-26-042237-index.html | 0001628280-26-042237 |
| Document: 0001628280-26-042237.txt | 0001628280-26-042237 |
18 reports for VIR
40% Hit rate best @ T+60▲ +10.12%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Court Ruling | $9.24 $9.78 | ▲ +5.84% | ▲ +7.21% | $11.17 (+20.89%) |
Aug 9, 2026 7w ago | Institutional Cluster | $8.89 $9.39 | ▲ +5.62% | ▲ +5.67% | $11.17 (+25.65%) |
Jul 24, 2026 10w ago | 8-K | $8.69 $8.90 | ▲ +2.42% | ▲ +2.04% | $11.17 (+28.54%) |
Jun 29, 2026 13w ago | 144 | $10.38 $10.02 | ▼ −3.47% | ▼ −4.86% | $11.17 (+7.61%) |
Jun 10, 2026 16w ago | 3 | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 10, 2026 16w ago | 8-K | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 2, 2026 17w ago | Insider Cluster | $8.77 $8.25 | ▼ −5.93% | ▼ −2.11% | $11.17 (+27.37%) |
May 28, 2026 18w ago | 8-K | $9.55 $8.77 | ▼ −8.17% | ▼ −8.12% | $11.17 (+16.96%) |
Apr 16, 2026 24w ago | DEFA14A | $10.33 $10.35 | ▲ +0.19% | ▼ −0.79% | $11.17 (+8.13%) |
Apr 10, 2026 25w ago | 8-K | $9.31 $11.09 | ▲ +19.12% | ▲ +15.82% | $11.17 (+19.98%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (65h)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access